Similar articles

• Controversies in family planning: pregnancy termination in women with uterine anatomic abnormalities.

  Goldthwaite LM, Teal SB. Goldthwaite LM, et al. Contraception. 2014 Oct;90(4):460-3. doi: 10.1016/j.contraception.2014.05.007. Epub 2014 May 17. Contraception. 2014. PMID: 24958107 Review. No abstract available.
• Treatment of suction termination of pregnancy-retained products with misoprostol markedly reduces the repeat operation rate.

  Chambers DG, Mulligan EC. Chambers DG, et al. Aust N Z J Obstet Gynaecol. 2009 Oct;49(5):551-3. doi: 10.1111/j.1479-828X.2009.01043.x. Aust N Z J Obstet Gynaecol. 2009. PMID: 19780743
• Intervention rates for placental removal following induction abortion with misoprostol.

  Green J, Borgatta L, Sia M, Kapp N, Saia K, Carr-Ellis S, Vragovic O. Green J, et al. Contraception. 2007 Oct;76(4):310-3. doi: 10.1016/j.contraception.2007.06.010. Epub 2007 Aug 28. Contraception. 2007. PMID: 17900443
• [Pregnancy termination in the second trimester with vaginally administered dinoprostone followed by intravenous sulprostone, for the indication 'foetal congenital defects'; results of a retrospective study].

  Willems FE. Willems FE. Ned Tijdschr Geneeskd. 2004 Aug 14;148(33):1656-7; author reply 1657. Ned Tijdschr Geneeskd. 2004. PMID: 15455517 Dutch. No abstract available.
• Controversies in family planning: management of lethal fetal anomalies in the third trimester.

  Perritt JB, Edelman AB, Burke AE. Perritt JB, et al. Contraception. 2012 Aug;86(2):93-5. doi: 10.1016/j.contraception.2011.09.006. Epub 2011 Nov 4. Contraception. 2012. PMID: 22056098 Review. No abstract available.